Valuation: Cellnovo

Market Cap 2.44M 2.1M 1.98M 1.8M 3.38M 233M 3.44M 23.16M 9.06M 117M 9.14M 8.95M 388M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.76M 10.11M 9.2M 17.29M 1.19B 17.57M 118M 46.32M 597M 46.77M 45.76M 1.98B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
-3.93%-11.56% - - 12.77B
+2.08%+1.50%-24.34%-40.94% 9.15B
+0.95%-1.70%+1.91%+113.31% 8.1B
+3.40%-17.47%-44.55%+191.38% 4.08B
+1.20%-1.17%-41.24%-13.91% 2.46B
-1.34%-2.65%-34.52%-33.69% 1.92B
+5.92%+6.85%+35.94%+91.57% 1.68B
-1.16%+2.02%+8.67%+70.19% 1.47B
+0.20%+1.01%+0.64%+104.35% 1.38B
Average +0.73%-3.58%-12.19%+60.28% 4.3B
Weighted average by Cap. -0.02%-5.72%-15.96%+53.78%

Financials

2018 2019 *
Net sales 3.32M 2.87M 2.7M 2.45M 4.61M 318M 4.69M 31.59M 12.35M 159M 12.47M 12.2M 529M -
Net income -15.94M -13.77M -12.94M -11.76M -22.12M -1.52B -22.48M -152M -59.26M -763M -59.84M -58.54M -2.54B -
Net Debt 10.02M 8.66M 8.13M 7.4M 13.91M 958M 14.14M 95.31M 37.26M 480M 37.63M 36.81M 1.59B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock